VEGFA and renal cell carcinoma: Renal cell carcinoma culture supernatants also inhibited IL-12 production, and neither of the drugs tested reversed this effect, further supporting the fact that IL-12 inhibition is dependent not on the VEGF pathway but on other unidentified factors.